Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$-- Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$0 Mln
ROE
0 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
0
Industry P/E
--
EV/EBITDA
0
Div. Yield
0 %
Debt to Equity
--
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
0
CFO
$-215.03 Mln
EBITDA
$-715.38 Mln
Net Profit
$-712.34 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BioPlus Acquisition Corp Unit (BIOSU)
| 5.9 | -0.9 | 0.6 | 7.2 | -- | -- | -- |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life... sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York. Read more
Chairman & Chief Bus. Officer
Mr. Jonathan M. N. Rigby MBA
Chairman & Chief Bus. Officer
Mr. Jonathan M. N. Rigby MBA
Headquarters
New York, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of BioPlus Acquisition Corp Unit (BIOSU) is $10.80 (NASDAQ) as of 13-Oct-2023 09:30 EDT. BioPlus Acquisition Corp Unit (BIOSU) has given a return of 7.25% in the last 1 years.
Since, TTM earnings of BioPlus Acquisition Corp Unit (BIOSU) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
1,180.98
|
27.34
|
|
2021
|
--
|
--
|
|
2018
|
--
|
--
|
|
2017
|
--
|
--
|
|
2016
|
--
|
--
|
The 52-week high and low of BioPlus Acquisition Corp Unit (BIOSU) are Rs -- and Rs -- as of 03-Apr-2026.
BioPlus Acquisition Corp Unit (BIOSU) has a market capitalisation of -- as on 13-Oct-2023. As per SEBI classification, it is a company.
Before investing in BioPlus Acquisition Corp Unit (BIOSU), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.